source
- Praxis sinks on late-stage study fail for seizure pill, halts second trialPraxis Precision Medicines has had a decent run over the past eight months or so, with two major clinical wins. But on Monday, the company disclosed a late-stage failure for its investigational sei…Endpoints · 1mo ago↗ source
- Obesity care startup Ilant Health raises $15MIlant Health has raised $15 million in a Series A funding round to expand its personalized approach to treating obesity. Ilant is one of many virtual care companies competing to help employers and…Endpoints · 1mo ago↗ source
- Updated: Allen Institute launches $400M effort to turn brain atlas lessons into medicinesA Seattle-based nonprofit known for basic brain research is launching a $400 million initiative to translate its knowledge into drug development for neurodegenerative diseases, including Alzheimer'…